• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

(1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride: A Comprehensive Overview

(1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride, identified by the CAS number 1391540-47-8, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound is a chiral amine derivative with a trifluoromethoxy substituent, which imparts unique chemical and biological properties. The hydrochloride salt form is commonly used in research and development due to its stability and solubility characteristics.

The structure of (1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride consists of a phenyl ring substituted with a trifluoromethoxy group at the para position, connected to an ethanamine backbone. The (1S) configuration indicates the specific stereochemistry at the chiral center, which is crucial for its biological activity. The trifluoromethoxy group is known for its electron-withdrawing properties, which can influence the compound's reactivity and interactions with biological systems.

Recent studies have highlighted the potential of (1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride as a lead compound in drug discovery. Its ability to modulate various biological pathways, including kinase activity and receptor binding, has been extensively investigated. For instance, research published in 2023 demonstrated its efficacy in inhibiting specific protein kinases involved in cancer cell proliferation, suggesting its potential as an anti-cancer agent.

The synthesis of this compound involves a multi-step process, typically starting with the preparation of the trifluoromethoxy aromatic intermediate. The introduction of the ethanamine group is achieved through nucleophilic substitution or coupling reactions, followed by acidification to obtain the hydrochloride salt. Optimization of these steps has led to improved yields and purity, making it more accessible for large-scale production.

In terms of applications, (1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride has shown promise in both therapeutic and diagnostic contexts. Its role as a chiral building block in medicinal chemistry has facilitated the development of enantiomerically pure compounds, which are essential for studying stereochemical effects on pharmacokinetics and efficacy. Additionally, its use as a ligand in metal-mediated catalysis has opened new avenues for asymmetric synthesis.

From an environmental perspective, understanding the fate and behavior of (1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride in natural systems is critical. Studies have shown that its degradation under aerobic conditions is relatively slow due to the stability imparted by the trifluoromethoxy group. However, advanced treatment methods such as photocatalytic oxidation have been shown to effectively break down the compound into less harmful byproducts.

In conclusion, (1S)-1-[4-(Trifluoromethoxy)Phenyl]Ethanamine Hydrochloride (CAS No. 1391540-47-8) stands out as a versatile compound with wide-ranging applications in chemistry and biology. Its unique structure, combined with recent advancements in synthesis and application techniques, positions it as a valuable tool for future research and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)